Immunoglobulin Homecare (Human Normal) (Hizentra)
- Belfast Health and Social Care Trust
- Northern Ireland
- Direct award
- 8 July 2026 to 24 September 2026
The contract covers the homecare delivery and clinical support services for Hizentra (Human Normal Immunoglobulin). This involves the supply chain management, patient-specific delivery, and clinical oversight required to support patients receiving immunoglobulin therapy in a home setting. The service is focused on the specific requirements for the safe handling, transport, and administration of this pharmaceutical product.
- Awarded value
- £600k
- As published
- Published
- 26 June 2026
- Contract length
- 3 months
- Ends 24 September 2026